Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 22:3:168.
doi: 10.3389/fimmu.2012.00168. eCollection 2012.

Mesenchymal stem cell-derived hepatocytes for functional liver replacement

Bruno Christ  1 , Peggy Stock
Affiliations

Mesenchymal stem cell-derived hepatocytes for functional liver replacement

Bruno Christ et al. Front Immunol. .

Abstract

Mesenchymal stem cells represent an alternate cell source to substitute for primary hepatocytes in hepatocyte transplantation because of their multiple differentiation potential and nearly unlimited availability. They may differentiate into hepatocyte-like cells in vitro and maintain specific hepatocyte functions also after transplantation into the regenerating livers of mice or rats both under injury and non-injury conditions. Depending on the underlying liver disease their mode of action is either to replace the diseased liver tissue or to support liver regeneration through their anti-inflammatory and anti-apoptotic as well as their pro-proliferative action.

Keywords: cell transplantation; hepatocyte; liver; mesenchymal stem cells.

PubMed Disclaimer

References

    1. Abdel Aziz M. T., Atta H. M., Mahfouz S., Fouad H. H., Roshdy N. K., Ahmed H. H., Rashed L. A., Sabry D., Hassouna A. A., Hasan N. M. (2007). Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin. Biochem. 40, 893–899 10.1016/j.clinbiochem.2007.04.017 - DOI - PubMed
    1. Aggarwal S., Pittenger M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815–1822 10.1182/blood-2004-04-1559 - DOI - PubMed
    1. Ailles L. E., Weissman I. L. (2007). Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 18, 460–466 10.1016/j.copbio.2007.10.007 - DOI - PubMed
    1. Akay I., Oxmann D., Helfenstein A., Mentlein R., Schünke M., Hassenpflug J., Kurz B. (2010). Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth. Osteoarthr. Cartil. 18, 389–396 10.1016/j.joca.2009.10.015 - DOI - PubMed
    1. Alison M., Islam S., Lim S. (2009). Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J. Pathol. 217, 282–298 10.1002/path.2453 - DOI - PubMed

LinkOut - more resources